CSP exam test 2024 (specialty pharmacy)With Correct Answers!!
PDC calculation - ✔✔(# of unique days with supply / number of days in a period) x 100 Jak inhibitor - ✔✔Xeljanz (tofacitinib) Cholesterol-elevating medication - ✔✔Actemra (toclizumab) Shingles vaccine safe with TNF inhibitors - ✔✔Shingrix Neutropenia risk - ✔✔Taltz (ixekizumab) Psoriasis medication without tuberculosis screening - ✔✔Otezla (apremilast) Standard starting dose for Taltz (ixekizumab) in psoriatic arthritis - ✔✔160mg subcutaneously once, followed by 80mg subcutaneously every 4 weeks Medication recommendation for severe dermatitis in a 45 y/o patient - ✔✔Dupixent (dupilumab) Starting dose for Stelara (ustekinumab) in psoriasis - ✔✔Inject 45 mg subcutaneously at weeks 0 and 4, followed by 45 mg every 12 weeks Oral oncology medication without caution in hepatic impairment - ✔✔Ibrance (palbociclib) Non-side effect of Zytiga (abiraterone acetate) - ✔✔Mucositis Smoking effect on Tarceva (erlotinib) levels - ✔✔Smoking decreases Tarceva levels and the medication will be less effective if he continues to smoke Oral oncology agents taken with food - ✔✔Xeloda (capecitabine) and Temodar (temozolomide) Recommended oncology treatment for metastatic HER 2+ breast cancer - ✔✔Tykerb (lapatinib) in combination with Xeloda (capecitabine) Incorrect oral chemotherapy cycle - ✔✔Afinitor (everolimus) 10mg daily for 21 days, then 7 days off Grapefruit and grapefruit juice interaction with oral chemotherapy - ✔✔Zytiga (abiraterone acetate) Transition from Exjade (deferasirox) to Jadenu (deferasirox) - ✔✔The Jadenu dose should be started at a dosage 30% less than current Exjade dose Oral antiandrogen for metastatic castration-resistant prostate cancer - ✔✔Xtandi (enzalutamide) 160mg once daily
- / 1